Image – Interventional flashlight

DOI: 10.4244/EIJ-D-19-00826

ACURATE neo valve perforation after valve-in-valve transcatheter aortic valve implantation

Andreas Rück1, MD, PhD; Magnus Settergren1, MD, PhD; Nawzad Saleh1, MD, PhD; Dinos Verouhis1, MD, PhD

Figure 1. Possible cause of perforated ACURATE neo valve. A) Fluoroscopy after valve-in-valve TAVI using the ACURATE neo inside a Biocor surgical bioprosthesis. Red arrow showing the same area as in panels B and C. B) Ex vivo image showing (red arrow) proximity of the upper edge of the stent post of the Biocor (outside) and the ACURATE neo prosthesis. Image courtesy of Dr Vinayat Bapat and UBQO Limited, London, UK. C) The explanted ACURATE neo, with a hole under the stent post between the right and left cusps (red arrow).

In 2001, a 61-year-old male was operated and a 25 mm Biocor™ (St. Jude Medical, St. Paul, MN, USA) aortic bioprosthesis was implanted. In 2017, the patient developed dyspnoea. Echocardiography revealed severe transvalvular regurgitation.

In January 2018, a transcatheter aortic valve implantation (TAVI) valve-in-valve procedure was performed using a 23 mm ACURATE neo™ prosthesis (Boston Scientific, Marlborough, MA, USA) (Figure 1A). The prosthesis was post-dilated with a 22 mm balloon. Postoperative and 30-day echocardiography was unremarkable.

In August 2018, the patient reported exertional dyspnoea. Echocardiography showed severe paravalvular and transvalvular aortic regurgitation. There were no signs of infection. Both prostheses were explanted and a PERIMOUNT Magna Ease 23 mm bioprosthesis (Edwards Lifesciences, Irvine, CA, USA) was successfully implanted. Recovery was uneventful.

The ACURATE neo TAVI prosthesis has a triangular area under each stent post which is covered with porcine pericardium but not protected by metal, possibly a weak spot. It was noticed that the stent posts of the Biocor prosthesis and the ACURATE neo were aligned (Figure 1B), putting the weak spot in contact with the top of the surgical bioprosthesis’ stent posts, and causing a hole at this location by abrasion (Figure 1C).

This mechanism of prosthesis failure may indicate that the ACURATE neo prosthesis should be used with caution in valve-in-valve procedures (Moving image 1),1.

Conflict of interest statement

A. Rück has received lecture honoraria, research support and proctor fees from Boston Scientific and Edwards Lifesciences. M. Settergren has received lecture honoraria and proctor fees from Abbott, Boston Scientific, Medtronic, W.L. Gore and Edwards Lifesciences. N. Saleh has received lecture honoraria and proctor fees from Boston Scientific. The other author has no conflicts of interest to declare.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Location of the perforation in the ACURATE neo prosthesis in the weak spot just below the stent post.

Volume 16 Number 7
Sep 18, 2020
Volume 16 Number 7
View full issue


Key metrics

Suggested by Cory

Research correspondence

10.4244/EIJ-D-22-00740 Apr 24, 2023
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis
Vanhaverbeke M et al
free

EXPERT REVIEW

10.4244/EIJ-D-18-00667 Sep 7, 2018
Novel strategies in aortic valve-in-valve therapy including bioprosthetic valve fracture and BASILICA
Dvir D et al
free

State-of-the-Art

10.4244/EIJ-D-23-01050 Jul 15, 2024
Durability of transcatheter aortic valve implantation
Ternacle J et al
free

10.4244/EIJV7I1A25 May 17, 2011
How should I treat acute valve regurgitation?
Schultz C et al
free

AORTIC VALVE INTERVENTIONS

10.4244/EIJV12SYA8 Sep 18, 2016
Late degeneration of transcatheter aortic valves: pathogenesis and management
Barbanti M and Tamburino C
free
Trending articles
309.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
72.85

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved